These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 19381758

  • 1. Nephrotic-range proteinuria in a patient with a renal allograft treated with sorafenib for metastatic renal-cell carcinoma.
    Jonkers IJAM, van Buren M.
    Clin Exp Nephrol; 2009 Aug; 13(4):397-401. PubMed ID: 19381758
    [Abstract] [Full Text] [Related]

  • 2. Nephrotic syndrome caused by the angiogenesis inhibitor sorafenib.
    Overkleeft EN, Goldschmeding R, van Reekum F, Voest EE, Verheul HM.
    Ann Oncol; 2010 Jan; 21(1):184-5. PubMed ID: 19889617
    [No Abstract] [Full Text] [Related]

  • 3. Arterial hypertension and clinical benefit of sunitinib, sorafenib and bevacizumab in first and second-line treatment of metastatic renal cell cancer.
    Ravaud A, Sire M.
    Ann Oncol; 2009 May; 20(5):966-7; author reply 967. PubMed ID: 19403939
    [No Abstract] [Full Text] [Related]

  • 4. Sunitinib- and sorafenib-induced nephrotic syndrome in a patient with gastrointestinal stromal tumor.
    Turan N, Benekli M, Ozturk SC, Inal S, Memis L, Guz G, Cetin B, Buyukberber S.
    Ann Pharmacother; 2012 Oct; 46(10):e27. PubMed ID: 23032654
    [Abstract] [Full Text] [Related]

  • 5. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
    Rini BI, Escudier B, Tomczak P, Kaprin A, Szczylik C, Hutson TE, Michaelson MD, Gorbunova VA, Gore ME, Rusakov IG, Negrier S, Ou YC, Castellano D, Lim HY, Uemura H, Tarazi J, Cella D, Chen C, Rosbrook B, Kim S, Motzer RJ.
    Lancet; 2011 Dec 03; 378(9807):1931-9. PubMed ID: 22056247
    [Abstract] [Full Text] [Related]

  • 6. Acute exacerbation of hemorrhagic rectocolitis during antiangiogenic therapy with sunitinib and sorafenib.
    Loriot Y, Boudou-Rouquette P, Billemont B, Ropert S, Goldwasser F.
    Ann Oncol; 2008 Nov 03; 19(11):1975. PubMed ID: 18723549
    [No Abstract] [Full Text] [Related]

  • 7. [Angiogenesis and renal cell carcinoma].
    Billemont B, Méric JB, Izzedine H, Taillade L, Sultan-Amar V, Rixe O.
    Bull Cancer; 2007 Jul 03; 94 Spec No():S232-40. PubMed ID: 17846009
    [Abstract] [Full Text] [Related]

  • 8. Acute aortic dissection during sorafenib-containing therapy.
    Serrano C, Suárez C, Andreu J, Carles J.
    Ann Oncol; 2010 Jan 03; 21(1):181-2. PubMed ID: 19858082
    [No Abstract] [Full Text] [Related]

  • 9. Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma.
    Kodaira M, Takahashi S, Takeuchi K, Yuasa T, Saotome T, Yonese J, Fukui I, Hatake K.
    Ann Oncol; 2010 Jul 03; 21(7):1563-1565. PubMed ID: 20573851
    [No Abstract] [Full Text] [Related]

  • 10. Frequent dose interruptions are required for patients receiving oral kinase inhibitor therapy for advanced renal cell carcinoma.
    La Vine DB, Coleman TA, Davis CH, Carbonell CE, Davis WB.
    Am J Clin Oncol; 2010 Jun 03; 33(3):217-20. PubMed ID: 19745694
    [Abstract] [Full Text] [Related]

  • 11. [Managing the side effects of angiogenetic inhibitors in metastatic renal cell carcinoma].
    Staehler M, Haseke N, Schöppler G, Stadler T, Heinemann G, Stief CG.
    Urologe A; 2006 Oct 03; 45(10):1333-42; quiz 1343. PubMed ID: 17021905
    [Abstract] [Full Text] [Related]

  • 12. Sorafenib-induced eruptive melanocytic lesions.
    Kong HH, Sibaud V, Chanco Turner ML, Fojo T, Hornyak TJ, Chevreau C.
    Arch Dermatol; 2008 Jun 03; 144(6):820-2. PubMed ID: 18559790
    [No Abstract] [Full Text] [Related]

  • 13. Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib.
    Tamaskar I, Bukowski R, Elson P, Ioachimescu AG, Wood L, Dreicer R, Mekhail T, Garcia J, Rini BI.
    Ann Oncol; 2008 Feb 03; 19(2):265-8. PubMed ID: 17962201
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal Antivascular Endothelial Growth Factor Therapy May Induce Proteinuria and Antibody Mediated Injury in Renal Allografts.
    Cheungpasitporn W, Chebib FT, Cornell LD, Brodin ML, Nasr SH, Schinstock CA, Stegall MD, Amer H.
    Transplantation; 2015 Nov 03; 99(11):2382-6. PubMed ID: 25905984
    [Abstract] [Full Text] [Related]

  • 15. Recurrence of IgA nephropathy with nephrotic syndrome in renal allograft.
    Pettersson E, Honkanen E, Törnroth T.
    Nephron; 1985 Nov 03; 41(1):114-7. PubMed ID: 3897883
    [Abstract] [Full Text] [Related]

  • 16. Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma.
    Mego M, Reckova M, Obertova J, Sycova-Mila Z, Brozmanova K, Mardiak J.
    Ann Oncol; 2007 Nov 03; 18(11):1906-7. PubMed ID: 17993633
    [No Abstract] [Full Text] [Related]

  • 17. [Squamous cell carcinoma in a patient receiving sorafenib].
    Adnot-Desanlis L, Bernard P, Reguiaï Z.
    Ann Dermatol Venereol; 2011 Feb 03; 138(2):120-3. PubMed ID: 21333823
    [Abstract] [Full Text] [Related]

  • 18. Interstitial pneumonia probably associated with sorafenib treatment: An alert of an adverse event.
    Ide S, Soda H, Hakariya T, Takemoto S, Ishimoto H, Tomari S, Sawai T, Nagashima S, Furukawa M, Nakamura Y, Kohno S.
    Lung Cancer; 2010 Feb 03; 67(2):248-50. PubMed ID: 19897274
    [Abstract] [Full Text] [Related]

  • 19. A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib.
    Patel TV, Morgan JA, Demetri GD, George S, Maki RG, Quigley M, Humphreys BD.
    J Natl Cancer Inst; 2008 Feb 20; 100(4):282-4. PubMed ID: 18270341
    [No Abstract] [Full Text] [Related]

  • 20. [Use of sorafenib in patients with hepatocellular or renal carcinoma].
    Rosmorduc O, Chevreau C, Dielenseger P, Ederhy S, Goldwasser F, Grange JD, Mortier L, Neidhardt-Berard ME, Robert C, Scotté F, Seitz JF.
    Gastroenterol Clin Biol; 2010 Mar 20; 34(3):161-7. PubMed ID: 20181452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.